Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.

Muto V, Stellacci E, Lamberti AG, Perrotti E, Carrabba A, Matera G, Sgarbanti M, Battistini A, Liberto MC, Focà A.

J Virol. 2011 May;85(10):5070-80. doi: 10.1128/JVI.02114-10. Epub 2011 Mar 9.

2.

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

Lace MJ, Anson JR, Klingelhutz AJ, Harada H, Taniguchi T, Bossler AD, Haugen TH, Turek LP.

Carcinogenesis. 2009 Aug;30(8):1336-44. doi: 10.1093/carcin/bgp150. Epub 2009 Jun 18.

3.

Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

Herdman MT, Pett MR, Roberts I, Alazawi WO, Teschendorff AE, Zhang XY, Stanley MA, Coleman N.

Carcinogenesis. 2006 Nov;27(11):2341-53. Epub 2006 Sep 14.

4.

High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Reiser J, Hurst J, Voges M, Krauss P, Münch P, Iftner T, Stubenrauch F.

J Virol. 2011 Nov;85(21):11372-80. doi: 10.1128/JVI.05279-11. Epub 2011 Aug 17.

5.

Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA, Coleman N.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3822-7. Epub 2006 Feb 27.

6.

Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway.

French D, Belleudi F, Mauro MV, Mazzetta F, Raffa S, Fabiano V, Frega A, Torrisi MR.

Mol Cancer. 2013 May 7;12:38. doi: 10.1186/1476-4598-12-38.

7.
9.

Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.

Lace MJ, Anson JR, Haugen TH, Turek LP.

Virology. 2010 Apr 10;399(2):270-9. doi: 10.1016/j.virol.2009.12.025. Epub 2010 Feb 2.

10.

Human papillomavirus 16 E5 modulates the expression of host microRNAs.

Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, Auvinen E.

PLoS One. 2011;6(7):e21646. doi: 10.1371/journal.pone.0021646. Epub 2011 Jul 1.

11.

HPV: from infection to cancer.

Stanley MA, Pett MR, Coleman N.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1456-60. Review.

PMID:
18031245
12.

Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.

Liao S, Deng D, Zhang W, Hu X, Wang W, Wang H, Lu Y, Wang S, Meng L, Ma D.

Oncol Rep. 2013 Jan;29(1):95-102. doi: 10.3892/or.2012.2106. Epub 2012 Oct 26.

PMID:
23128977
13.

HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic.

Belleudi F, Leone L, Purpura V, Cannella F, Scrofani C, Torrisi MR.

Oncogene. 2011 Dec 15;30(50):4963-76. doi: 10.1038/onc.2011.203. Epub 2011 May 30.

PMID:
21625213
14.

In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Gray E, Pett MR, Ward D, Winder DM, Stanley MA, Roberts I, Scarpini CG, Coleman N.

Cancer Res. 2010 May 15;70(10):4081-91. doi: 10.1158/0008-5472.CAN-09-3335. Epub 2010 May 4.

15.

HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.

Cardeal LB, Boccardo E, Termini L, Rabachini T, Andreoli MA, di Loreto C, Longatto Filho A, Villa LL, Maria-Engler SS.

PLoS One. 2012;7(3):e33585. doi: 10.1371/journal.pone.0033585. Epub 2012 Mar 16.

16.

Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.

Oldak M, Tolzmann L, Wnorowski A, Podgórska MJ, Silling S, Lin R, Hiscott J, Müller CS, Vogt T, Smola H, Smola S.

J Virol. 2011 Jan;85(1):178-88. doi: 10.1128/JVI.00998-10. Epub 2010 Oct 27.

17.

Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.

Genther SM, Sterling S, Duensing S, Münger K, Sattler C, Lambert PF.

J Virol. 2003 Mar;77(5):2832-42.

18.

HPV16 activates the AIM2 inflammasome in keratinocytes.

Reinholz M, Kawakami Y, Salzer S, Kreuter A, Dombrowski Y, Koglin S, Kresse S, Ruzicka T, Schauber J.

Arch Dermatol Res. 2013 Oct;305(8):723-32. doi: 10.1007/s00403-013-1375-0. Epub 2013 Jun 14.

PMID:
23764897
19.

Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.

Hyland PL, McDade SS, McCloskey R, Dickson GJ, Arthur K, McCance DJ, Patel D.

J Virol. 2011 Nov;85(21):10999-1006. doi: 10.1128/JVI.00160-11. Epub 2011 Aug 24.

20.

Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.

Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, Bachmann A, Ritter TM, Dondog B, Ly R, Bosch FX, Zawatzky R, Rösl F.

Cancer Res. 2009 Nov 15;69(22):8718-25. doi: 10.1158/0008-5472.CAN-09-0550. Epub 2009 Nov 3.

Items per page

Supplemental Content

Write to the Help Desk